Kenny D, Cooke A, Tempany E, McGeeney K F
Clin Chim Acta. 1978 Nov 1;89(3):429-33. doi: 10.1016/0009-8981(78)90406-0.
A new method which uses a differential inhibitor to measure pancreatic and salivary type alpha-amylases (EC 3.2.1.1) was applied to serum samples from 46 cystic fibrosis (CF) patients (age range 4-14 years) and 50 controls of the same age group. The levels of pancreatic type amylase were lower in the CF patients (median 26.5 I.U./1) than the controls (median 81.5) (P less than 0.001). The results for salivary-type enzyme, however, did not support the previously reported finding of higher than usual levels in CF patients. This discrepancy is probably due to differences in analytical methods. It is felt that this procedure will be of value in the investigation of patients for cystic fibrosis and other pancreatic disorders.
一种使用差分抑制剂来测量胰腺型和唾液型α淀粉酶（EC 3.2.1.1）的新方法被应用于46例囊性纤维化（CF）患者（年龄范围4至14岁）和50例同年龄组对照的血清样本。CF患者的胰腺型淀粉酶水平（中位数26.5国际单位/升）低于对照组（中位数81.5）（P<0.001）。然而，唾液型酶的结果并不支持先前报道的CF患者中该酶水平高于正常的发现。这种差异可能是由于分析方法的不同。人们认为该方法在囊性纤维化和其他胰腺疾病患者的调查中将具有价值。
